Cargando…
Expression profiles analysis identifies specific interferon-stimulated signatures as potential diagnostic and predictive indicators of JAK2V617F (+) myelofibrosis
Objective: This study aimed to identify specific dysregulated genes with potential diagnostic and predictive values for JAK2V617F (+) myelofibrosis. Methods: Two gene expression datasets of CD34(+) hematopoietic stem and progenitor cells (HSPCs) from patients with JAK2V617F (+) myeloproliferative ne...
Autores principales: | Zhao, Yanhong, Wang, Di, Liang, Yipeng, Xu, Changlu, Shi, Lihong, Tong, Jingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434717/ https://www.ncbi.nlm.nih.gov/pubmed/36061178 http://dx.doi.org/10.3389/fgene.2022.927018 |
Ejemplares similares
-
JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis
por: Barosi, Giovanni, et al.
Publicado: (2013) -
JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis
por: Kim, Bo Hyun, et al.
Publicado: (2015) -
Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis
por: Shimizu, Takafumi, et al.
Publicado: (2016) -
Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
por: Yönal, İpek, et al.
Publicado: (2016) -
Effect of NS-018, a selective JAK2V617F inhibitor, in a murine model of myelofibrosis
por: Nakaya, Y, et al.
Publicado: (2014)